Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)

Mamoru Ayusawa; Tomoyoshi Sonobe; Shigeru Uemura; Shunnichi Ogawa; Yoshikazu Nakamura; Nobuyuki Kiyosawa; Masahiro Ishii; Kensuke Harada; Kawasaki Disease Research Committee

doi:10.1111/j.1442-200x.2005.02033.x

Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)

Pediatr Int. 2005 Apr;47(2):232-4. doi: 10.1111/j.1442-200x.2005.02033.x.

Authors

Mamoru Ayusawa¹, Tomoyoshi Sonobe, Shigeru Uemura, Shunnichi Ogawa, Yoshikazu Nakamura, Nobuyuki Kiyosawa, Masahiro Ishii, Kensuke Harada; Kawasaki Disease Research Committee

Affiliation

¹ Department of Pediatrics, Nihon University School of Medicine, Tokyo 173-8610, Japan. maysw@med.nihon-u.ac.jp

PMID: 15771703
DOI: 10.1111/j.1442-200x.2005.02033.x

Abstract

Diagnostic guidelines for Kawasaki Disease was revised to meet the present situation in 2002. This issue intends to explain new guidelines and their backgrounds. Major alterations are interpretation of cases with 4 or fewer febrile days shortened by early intravenous immunoglobulin treatment, and the clinical importance of atypical (incomplete, or suspected) cases.

Publication types

Guideline
Practice Guideline

MeSH terms

Humans
Immunoglobulins, Intravenous / therapeutic use
Mucocutaneous Lymph Node Syndrome / diagnosis*
Mucocutaneous Lymph Node Syndrome / drug therapy

Substances

Immunoglobulins, Intravenous